<SUBMISSION>
<ACCESSION-NUMBER>0001004980-05-000097
<TYPE>S-3/A
<PUBLIC-DOCUMENT-COUNT>4
<FILING-DATE>20050317
<DATE-OF-FILING-DATE-CHANGE>20050316
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>PG&E CORP
<CIK>0001004980
<ASSIGNED-SIC>4931
<IRS-NUMBER>943234914
<STATE-OF-INCORPORATION>CA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>S-3/A
<ACT>33
<FILE-NUMBER>333-121518
<FILM-NUMBER>05687006
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>ONE MARKET SPEAR TOWER
<STREET2>SUITE 2400
<CITY>SAN FRANCISCO
<STATE>CA
<ZIP>94105
<PHONE>4152677000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>ONE MARKET SPEAR TOWER
<STREET2>SUITE 2400
<CITY>SAN FRANCISCO
<STATE>CA
<ZIP>94105
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>PG&E PARENT CO INC
<DATE-CHANGED>19951214
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>S-3/A
<SEQUENCE>1
<FILENAME>s3-amendment1.htm
<DESCRIPTION>AMENDMENT NO.1
<TEXT>
<html>
<head>
<title>Amendment No. 1 to Form S-3</title>
</head>
<body link="blue" vlink="purple">
<div>
<p align="center"><b>As filed with the Securities and Exchange
Commission on March 17, 2005<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registration No. 333-121518</b></p>

<table border="1" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" valign="top">
<p align="center"><b>SECURITIES AND EXCHANGE COMMISSION<br>
<font size="2">WASHINGTON, D.C. 20549<br>
</font></b>_________________________________<br>
<b>Amendment No. 1<br>
to<br>
Form S-3</b></p>

<p align="center"><b>REGISTRATION STATEMENT<br>
UNDER<br>
THE SECURITIES ACT OF 1933<br>
</b>_________________________________</p>

<p align="center"><b><font size="5">PG&amp;E Corporation</font></b></p>

<p align="center"><i>(Exact Name of Registrant as Specified in Its
Charter)</i></p>
</td>
<td>
<p>&nbsp;</p>
</td>
</tr>

<tr>
<td valign="top">
<p align="center"><b>California</b><br>
 <i>(State or Other Jurisdiction of Incorporation or
Organization)</i></p>
</td>
<td valign="top">
<p align="center"><b>One Market Street, Spear Tower, Suite
2400<br>
San Francisco, CA 94105<br>
(415) 267-7000</b></p>

<p align="center">(Address, Including Zip Code, and Telephone
Number, Including Area Code, of Registrant&rsquo;s Principal
Executive Offices)</p>

<p align="center">_____________________________</p>

<p align="center"><b>Bruce R. Worthington<br>
One Market Street, Spear Tower, Suite
2400<br>
San Francisco, CA 94105<br>
(415) 267-7000</b></p>

<p align="center"><i>(Name, Address, Including Zip Code, and
Telephone Number,<br>
Including Area Code, of Agent for
Service)<br>
</i>_____________________________<br>
<i>Copies To:<br>
</i><b>Leslie P. Jay, Esq.<br>
Orrick, Herrington &amp; Sutcliffe LLP<br>
The Orrick Building<br>
405 Howard Street<br>
San Francisco, California&nbsp;
94105-2669<br>
(415) 773-5700</b></p>

<p align="center">_____________________________</p>
</td>
<td valign="top">
<p align="center"><b>94-3234914<br>
</b><i>(I.R.S. Employer<br>
Identification Number)</i></p>

</td>
<td>
<p>&nbsp;</p>
</td>
</tr>

<tr>
<td colspan="4" valign="top">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>Approximate date
of commencement of proposed sale to the public:</b>&nbsp; From time
to time after this registration statement becomes effective.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the only
securities being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the
following box. [&nbsp;]</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If any of the
securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in
connection with dividend or interest reinvestment plans, check the
following box. [x]</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If this Form is filed
to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, please check the following box and
list the Securities Act registration statement number of the
earlier effective registration statement for the same
offering.&nbsp;[&nbsp;] _____________</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If this Form is a
post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration
statement for the same offering.[&nbsp;]&nbsp; ______________</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If delivery of the
prospectus is expected to be made pursuant to Rule 434, please
check the following box. [&nbsp;]</p>
</td>
</tr>

<tr>
<td colspan="4" valign="top">
<p align="center">__________________________________</p>
</td>
</tr>

<tr>
<td colspan="4" valign="top">
<p><b>The registrant hereby amends this registration statement on
such date or dates as may be necessary to delay its effective date
until the registrant shall file a further amendment which
specifically states that this registration statement shall
thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until this registration statement shall
become effective on such date as the Commission, acting pursuant to
said Section 8(a), may determine.</b></p>
</td>
</tr>
</table>
</div>

<hr>
&nbsp;


<div>
<p><b>The information contained in this prospectus is not complete
and may be changed.&nbsp; We may not sell these securities until
the registration statement filed with the Securities and Exchange
Commission is effective.&nbsp; This prospectus is not an offer to
sell these securities and we are not soliciting offers to buy these
securities in any jurisdiction where the offer or sale is not
permitted.</b></p>

<p align="center"><b>Subject to completion, dated March 17,
2005</b></p>

<p><b>PROSPECTUS</b></p>

<p align="center"><font face="Arial" size="5"><i><b>PG&amp;E CORPORATION</b></i></font></p>

<p align="center"><b>$1,000,000,000</b></p>

<p align="center"><b>Common Stock</b></p>

<p align="center"><b>__________________</b></p>

<p>This prospectus includes a general description of the common
stock we may issue from time to time.&nbsp; We will provide
specific terms for any offering of common stock in one or more
supplements to this prospectus.&nbsp; This prospectus may not be
used to sell our common stock unless it is accompanied by a
prospectus supplement.&nbsp; You should read this prospectus and
any supplement to this prospectus carefully before you invest.</p>

<p>The aggregate initial offering price of the common stock sold
under this prospectus will not exceed $1,000,000,000.</p>

<p>Our common stock is listed on the New York Stock Exchange and
Pacific Exchange under the symbol &ldquo;PCG.&rdquo;</p>

<p align="center">__________________</p>

<p><b>NONE OF THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE
SECURITIES COMMISSION OR ANY OTHER REGULATORY BODY HAS APPROVED OR
DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS
A CRIMINAL OFFENSE.</b></p>

<p align="center">__________________</p>

<p align="center">The date of this prospectus is March __,
2005.</p>
</div>

<hr>
&nbsp;


<div>
<p align="center">TABLE OF CONTENTS</p>

<p align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Page</u></p>

<table border="0" cellpadding="0" cellspacing="0" width="650">
  <tr>
    <td width="784"><font color="#000000">About This Prospectus<br>
      Forward-Looking&nbsp;Statements&nbsp;<br>
      PG&amp;E&nbsp;Corporation<br>
      </font>Use of Proceeds<br>
      <font color="#000000">Description of Capital Stock<br>
      Plan of Distribution<br>
      Legal Matters<br>
      Experts<br>
      Where You Can Find More Information</font></td>
    <td width="103">
      <p align="center">ii<br>
      1<br>
      1<br>
      1<br>
      2<br>
      2<br>
      4<br>
      4<br>
      5</td>
  </tr>
  <tr>
    <td width="784"></td>
    <td width="103">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
  </tr>
</table>

<p align="center"><b>ABOUT THIS PROSPECTUS<br>
</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus
is part of a registration statement that we
filed with the Securities and Exchange Commission, or SEC, using a
&ldquo;shelf&rdquo; registration process.&nbsp; Using this process,
we may offer from time to time shares of common stock with an
aggregate value of up to $1.0 billion.&nbsp; Each time we offer
common stock, in addition to this prospectus we will provide you
with a prospectus supplement that will contain specific information
about the offering.&nbsp; The prospectus supplement may also add,
update or change information contained in this prospectus.&nbsp;
You should read this prospectus and any prospectus supplement as
well as additional information described under &ldquo;Where You Can
Find More Information&rdquo; on page 5.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus incorporates business and financial information
about us that is not included in or delivered with this
prospectus.&nbsp; You should rely only on the information contained
or incorporated by reference in this prospectus and any prospectus
supplement.&nbsp; We have not authorized any other person to
provide you with different or additional information.&nbsp; If
anyone provides you with different or additional information, you
should not rely on it.&nbsp; You should assume that the information
contained in this prospectus is accurate only as of the date of
this prospectus, that the information contained in any prospectus
supplement is accurate only as of the date of the applicable
prospectus supplement and that any information incorporated by
reference is accurate only as of the date of the document
incorporated by reference, regardless of the time of its
delivery.&nbsp; Our business, financial condition, results of
operations and prospects may have changed since those dates.&nbsp;
We are not making or soliciting an offer of any securities other
than the common stock described in this prospectus and any
prospectus supplement. We are not making or soliciting an offer of
these securities in any state or jurisdiction where the offer is
not permitted or in any circumstances in which such offer or
solicitation is unlawful.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information incorporated by reference into this prospectus
is available without charge upon written or oral request to The
Office of the Corporate Secretary, PG&amp;E Corporation, One Market
Street, Spear Tower, Suite 2400, San Francisco, California 94105,
telephone number (415) 267&#8209;7070.&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When used in this prospectus and unless otherwise specified, the
term:</p>

<blockquote>
  <ul>
    <li>&ldquo;Utility&rdquo; refers to our subsidiary Pacific Gas and
Electric Company; and<br>
      <br>
    </li>
    <li>&ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo; refer
to PG&amp;E Corporation and its consolidated subsidiaries.</li>
  </ul>
</blockquote>
</div>

<br clear="all">


<hr>


<div>
<p align="center"><b><a name="_Toc88981174">FORWARD&#8209;LOOKING
STATEMENTS</a><br>
</b>
</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The documents incorporated herein by
reference contain<font face="Times New Roman" size="3">,
and the applicable prospectus supplement will contain, </font>various forward-looking statements.&nbsp;
These forward-looking statements can be identified by the use
of words such as &ldquo;assume,&rdquo; &ldquo;expect,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo;
&ldquo;believe,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;predict,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;may,&rdquo;
&ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;would,&rdquo; &ldquo;could,&rdquo; &ldquo;goal,&rdquo;
&ldquo;potential&rdquo; and similar expressions.&nbsp; We have
based these forward&#8209;looking statements on our current
expectations and projections about future events, our assumptions
regarding these events and our knowledge of facts at the time the
statements were made.&nbsp; These forward&#8209;looking statements
are subject to various risks and uncertainties that may be outside
our control, and our actual results could differ materially from
our projected results.&nbsp; These risks and uncertainties include,
among other things:</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For a discussion
of these risks and uncertainties and the additional factors that could affect the validity of our
forward&#8209;looking statements, you should read the section of the documents
incorporated herein by reference titled "Risk Factors,"
as well as any additional discussion of these risks and uncertainties that may
be set forth in the applicable prospectus supplement.</p>
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should read this prospectus, the applicable prospectus
supplement, the documents that we incorporate by reference into
this prospectus, the documents that we have filed as exhibits to
the registration statement of which this prospectus is a part and
the documents that we refer to under the section of this prospectus
titled &ldquo;Where You Can Find More Information&rdquo; completely
and with the understanding that our actual future results could be
materially different from what we currently expect.&nbsp; We
qualify all our forward&#8209;looking statements by these
cautionary statements.&nbsp; These forward&#8209;looking statements
speak only as of&nbsp; the date of the
applicable prospectus supplement or the date of the document
incorporated by reference, as applicable.&nbsp; Except as required
by applicable laws or regulations, we do not undertake any
obligation to update or revise any forward&#8209;looking statement,
whether as a result of new information, future events or
otherwise.</p>
<hr>

<b><br clear="all">
</b>

<p align="center"><a name="_Toc88981175"><b>PG&amp;E
CORPORATION</b></a></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are an energy based holding company headquartered in San Francisco,
California that conducts its business principally through the
Utility, a public utility operating in northern and central
California.&nbsp; The Utility engages primarily in the businesses
of electricity and natural gas distribution, electricity
generation, procurement and&nbsp; transmission, and natural gas
procurement, transportation and storage.</p>

<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
executive offices are located at One Market Street, Spear Tower,
Suite 2400, San Francisco, California 94105, and our telephone
number is (415) 267-7000.<br>
</p>

<p align="center"><a name="_Toc88981177"><b>USE OF PROCEEDS</b></a></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise specified in a prospectus supplement, we will
use the net proceeds from the sale of the common stock offered by
this prospectus:</p>

<blockquote>
  <ul>
    <li>to redeem, repurchase, repay or retire outstanding indebtedness;
or</li>
  </ul>
  <ul>
    <li>for other general corporate purposes.</li>
  </ul>
</blockquote>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may invest the net proceeds temporarily until we use them for
their stated purposes.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, as described in this prospectus under the caption
&ldquo;Plan of Distribution&mdash;Other Transactions with Third
Parties,&rdquo; we may enter into derivative, forward or other
contracts with third parties indexed to or that may be settled in
our common stock or certain other transactions with third
parties.&nbsp; If specified in the applicable prospectus
supplement, we may use the common stock covered by this prospectus
to satisfy our obligations under such transactions.&nbsp; If we use
the common stock in this manner, we will not receive any proceeds
from the sale of those shares.</p>

<p align="center"><b>DESCRIPTION OF CAPITAL STOCK</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless indicated differently in a prospectus supplement, this
section describes the terms of our common stock and preferred
stock.&nbsp; The following description is only a summary and is
qualified in its entirety by reference to applicable law, our
restated articles of incorporation and our bylaws.&nbsp; Copies of
our restated articles of incorporation and bylaws are incorporated
by reference as exhibits to the registration statement of which
this prospectus is a part.</p>

<p><b>Common Stock</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our restated articles of incorporation authorize the issuance of
800,000,000 shares of common stock.&nbsp; We may issue our common
stock from time to time upon such terms and for such consideration
as may be determined by our board of directors.&nbsp; Such further
issuances, up to the aggregate amount authorized by our restated
articles of incorporation, will not require approval by our
shareholders.&nbsp; We may also issue common stock from time to
time under dividend reinvestment and employee benefit
plans.&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided by law, holders of our common stock
have voting rights on the basis of one vote per share on each
matter submitted to a vote at a meeting of shareholders, subject to
any class or series voting rights of holders of our preferred
stock.&nbsp; Our shareholders may not cumulate votes in elections
of directors.&nbsp; As a result, the holders of our common stock
and (if issued) preferred stock entitled to exercise more than 50%
of the voting rights in an election of directors can elect all of
the directors to be elected if they choose to do so.&nbsp; In such
event, the holders of the remaining common stock and preferred
stock voting for the election of directors will not be able to
elect any persons to the board of directors.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of our common stock, subject to any prior rights or
preferences of preferred stock outstanding, have equal rights to
receive dividends if and when declared by our board of directors
out of funds legally available therefor.&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of our liquidation, dissolution or winding up and
after payment of all prior claims, holders of our common stock
would be entitled to receive any of our remaining assets, subject
to any preferential rights of holders of outstanding shares of
preferred stock.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of our common stock have no preemptive rights to
subscribe for additional shares of common stock or any of our other
securities, nor do holders of our common stock have any redemption
or conversion rights.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our common stock is listed on the New York Stock Exchange and
Pacific Exchange under the symbol &ldquo;PCG.&rdquo;</p>

<p><b>Preferred Stock</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors is authorized, pursuant to our restated
articles of incorporation, to issue up to 85,000,000 shares of
preferred stock in one or more series and to fix and determine the
number of shares of preferred stock of any series, to determine the
designation of any such series, to increase or decrease the number
of shares of any such series subsequent to the issue of shares of
that series, and to determine or alter the rights, preferences,
privileges and restrictions granted to or imposed upon any such
series.&nbsp; Currently, there are no shares of our preferred stock
outstanding.&nbsp; If issued, the preferred stock would rank, with
respect to dividends and upon our liquidation, dissolution or
winding up, senior to all classes or series of our common stock and
to all of our equity securities ranking junior to the preferred
stock.</p>

<p align="center"><a name="_Toc88981178"><b>PLAN OF
DISTRIBUTION</b></a></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may sell the common stock described in this prospectus from
time to time in one or more transactions:</p>

<blockquote>
  <blockquote>
    <p style="margin-left: 0; margin-right: 0">(a)&nbsp;&nbsp;&nbsp;to purchasers directly;<br>
    (b)&nbsp;&nbsp;&nbsp;to underwriters for public offering and sale by them;<br>
    (c)&nbsp;&nbsp;&nbsp;through dealers;<br>
    (d)&nbsp;&nbsp;&nbsp;through agents;<br>
    (e)&nbsp;&nbsp;&nbsp;through a combination of any of the foregoing methods of sale;
or<br>
    (f)&nbsp;&nbsp;&nbsp;&nbsp;as described below under &ldquo;&mdash;Other Transactions with
Third Parties.&rdquo;</p>
  </blockquote>

<p>We may distribute the common stock from time to time in one or
more transactions at:</p>

  <blockquote>

<p>(a)&nbsp;&nbsp;&nbsp;a fixed price or prices, which may be changed;<br>
(b)&nbsp;&nbsp;&nbsp;market prices prevailing at the time of sale;<br>
(c)&nbsp;&nbsp;&nbsp;prices related to such prevailing market prices; or<br>
(d)&nbsp;&nbsp;&nbsp;negotiated prices.</p>

  </blockquote>
</blockquote>

<p><b>Direct Sales</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may sell the common stock directly to institutional investors
or others.&nbsp; Each prospectus supplement will describe the
manner and terms of any sale of common stock.</p>

<p><b>To Underwriters</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When common stock is to be sold to underwriters, we will execute
an underwriting agreement with them at the time of the sale and
will name them in the prospectus supplement.&nbsp; The applicable
prospectus supplement will name any underwriter involved in a sale
of common stock.&nbsp; Underwriters acquire the common stock for
their own accounts as principal and may offer and sell the common
stock at a fixed price or prices, which may be changed, or from
time to time at market prices or at negotiated prices.&nbsp;
Underwriters may be deemed to have received compensation from us
from sales of common stock in the form of underwriting discounts or
commissions and may also receive commissions from purchasers of
common stock for whom they may act as agent.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriters may sell common stock to or through dealers, and
those dealers may receive compensation in the form of discounts,
concessions or commissions from the underwriters as well as from
the purchasers for whom they may act as agent.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in a prospectus supplement, the
obligations of any underwriters to purchase shares of common stock
will be subject to certain conditions set forth in the underwriting
agreement, and the underwriters will be obligated to purchase all
such shares of common stock if any are purchased.</p>

<p><b>Through Dealers</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may offer and sell common stock to one or more dealers who
would purchase the securities as principal. The dealers then may
resell the offered common stock to the public at fixed or varying
prices to be determined by those dealers at the time of resale. We
will set forth the names of the dealers and the terms of the
transaction in the prospectus supplement. Any initial public
offering price and any discounts or concessions allowed or
reallowed or paid to dealers may be changed from time to time.</p>

<p><b>Through Agents</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may offer and sell common stock on a continuous basis through
agents that become parties to an underwriting or distribution
agreement. We will name any agent involved in the offer and sale
and describe any commissions payable by us in the prospectus
supplement. Unless otherwise indicated in the prospectus
supplement, the agent will be acting on a reasonable efforts basis
during the appointment period.</p>

<p><b>Delayed Delivery Contracts</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we so specify in the applicable prospectus supplement, we
will authorize underwriters, dealers and agents to solicit offers
by certain institutions to purchase common stock pursuant to
contracts providing for payment and delivery on future dates.&nbsp;
Such contracts will be subject to only those conditions set forth
in the applicable prospectus supplement.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The underwriters, dealers and agents will not be responsible for
the validity or performance of the contracts.&nbsp; We will set
forth in the prospectus supplement relating to the contracts the
price to be paid for the common stock, the commissions payable for
solicitation of the contracts and the date in the future for
delivery of the common stock.</p>

<p><b>Other Transactions with Third Parties</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may enter into other transactions with third parties,
including derivative, forward or other contracts indexed to or that
may be settled in our common stock, or sell securities not covered
by this prospectus to third parties in privately negotiated
transactions.&nbsp; If we so specify in the applicable prospectus
supplement, in connection with such transactions, the third parties
may sell securities covered by this prospectus and the applicable
prospectus supplement, including in short sale transactions.&nbsp;
If so, the third party may use securities pledged by us or borrowed
from us or others to settle those sales or to close out any related
open borrowings of stock, and may use securities received from us
in settlement of derivative, forward or other transactions to close
out any related open borrowings of stock.&nbsp; The third party in
such sale transactions will be an underwriter and, if not
identified in this prospectus, will be identified in the applicable
prospectus supplement (or a post-effective amendment).&nbsp; Such
underwriters may include, among others, Goldman, Sachs &amp;
Co.</p>

<p><b>General Information</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriters, dealers and agents participating in any
distribution of the common stock may be deemed to be
&ldquo;underwriters&rdquo; as defined in the Securities Act of
1933, or Securities Act, and any discounts and commissions they
receive and any profit they realize on resale of the common stock
may be deemed to be underwriting discounts and commissions under
the Securities Act.&nbsp; Those underwriters, dealers and agents
may be entitled, under their agreements with us, to indemnification
by us against certain civil liabilities, including liabilities
under the Securities Act, to contribution by us to payments that
they may be required to make in respect of those civil liabilities,
and to reimbursement by us for certain expenses.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriters, dealers or agents and their associates may be
customers of, engage in transactions with or perform services for
us or our affiliates in the ordinary course of business.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any underwriters that purchase common stock for public offering
and sale may make a market in such common stock, but such
underwriters will not be obligated to do so and may discontinue any
market making at any time without notice.</p>

<p align="center"><a name="_Toc88981179"><b>LEGAL MATTERS</b></a></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the common stock has been passed on for us by
Gary&nbsp;P. Encinas, Chief Counsel, Corporate, for PG&amp;E
Corporation.&nbsp; Mr.&nbsp;Encinas and other members of the
PG&amp;E Corporation Law Department who participated in
consideration of legal matters related to the common stock,
together with members of their respective families, owned in the
aggregate, as of March 10, 2005, approximately 72,638 shares of our
common stock and options to purchase an additional 630,725
shares.&nbsp;</p>

<p align="center"><a name="_Toc88981180"><b>EXPERTS</b></a></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements, the related consolidated
financial statement schedules, and management&rsquo;s report on the
effectiveness of internal control over financial reporting
incorporated in this prospectus by reference from PG&amp;E
Corporation and subsidiaries Annual Report on Form 10-K have been
audited by Deloitte &amp; Touche LLP, an independent registered
public accounting firm, as stated in their reports which are
incorporated herein by reference (which reports (1) express an
unqualified opinion on the financial statements and financial
statement schedules and include an explanatory paragraph relating
to (i) PG&amp;E Corporation&rsquo;s adoption of new accounting
standards in 2004 related to the method of computing earnings per
share, (ii) PG&amp;E Corporation&rsquo;s and Pacific Gas and
Electric Company&rsquo;s adoption of new accounting standards in
2003 to account for asset retirement obligations and financial
instruments with characteristics of both liabilities and equity and
(iii) PG&amp;E Corporation&rsquo;s adoption of new accounting
standards in 2002 relating to accounting for goodwill and
intangible assets, impairment of long lived assets and certain
derivative contracts, (2) express an unqualified opinion on
management&rsquo;s assessment regarding the effectiveness of
internal control over financial reporting, and (3) express an
unqualified opinion on the effectiveness of internal control over
financial reporting), and have been so incorporated in reliance
upon the reports of such firm given upon their authority as experts
in accounting and auditing.</p>

<p align="center"><a name="_Toc88981181"><b>WHERE YOU CAN FIND MORE
INFORMATION</b></a></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We and the Utility each file annual, quarterly and current
reports, information statements and other information with the SEC
under File No.&nbsp;001-12609 and File No.&nbsp;001-02348,
respectively.&nbsp; These SEC filings are available to the public
over the Internet at the SEC&rsquo;s website at
http://www.sec.gov.&nbsp; You may also read and copy any of these
SEC filings at the SEC&rsquo;s public reference room at 450 Fifth
Street, N.W., Room 1200, Washington, D.C. 20549.&nbsp; Please call
the SEC at 1-800-SEC-0330 for further information on its public
reference room.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have &ldquo;incorporated by reference&rdquo; into this
prospectus certain information that we file with the SEC.&nbsp;
This means that we can disclose important business, financial and
other information in this prospectus by referring you to the
documents containing this information.&nbsp; All information
incorporated by reference is deemed to be part of this prospectus
except to the extent that the information is updated or superseded
by the information contained in this prospectus or any information
filed with the SEC.&nbsp; Any information that we subsequently file
with the SEC that is incorporated by reference, as described below,
will automatically update and supersede any previous information
that is part of this prospectus.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incorporate by reference the documents listed below and any
future filings (other than information furnished, and not filed,
pursuant to Items 2.02 or 7.01 in any Form 8&#8209;K filing or any
other item that permits us to furnish, rather than file,
information) we make with the SEC under Section 13(a), 13(c), 14 or
15(d) of the Exchange Act until the termination of the
offering:</p>

<blockquote>
  <ul>
    <li>our Annual Report on Form 10&#8209;K for the year ended December
31, 2004;</li>
  </ul>
  <ul>
    <li>the description of our common stock contained in our
Registration Statement on Form 8-B, including any subsequent
amendment or report filed for the purpose of updating such
information; and</li>
  </ul>
  <ul>
    <li>our Current Reports on Form 8&#8209;K filed on January 6, 2005,
February 1, 2005, February 11, 2005, February 18, 2005 (Item 8.01
only) and March&nbsp;7, 2005.</li>
  </ul>
</blockquote>

<p>You may request a copy of these filings at no cost by writing or
contacting us at the following address:</p>

<p align="center">The Office of the Corporate Secretary<br>
PG&amp;E Corporation<br>
One Market Street, Spear Tower<br>
Suite 2400<br>
San Francisco, CA 94105<br>
Telephone: 415-267-7070<br>
Facsimile: 415-267-7268</p>

</div>

<hr>
<p align="center">

<br clear="all">
<font face="Arial" size="5"><b><i>PG&amp;E CORPORATION
 <br clear="all">


</i></b></font>
<hr>


<div>
<p align="center"><b>PART II<br>
<br>
INFORMATION NOT REQUIRED IN PROSPECTUS</b></p>

<p><b>Item 14.&nbsp; Other Expenses of Issuance and Distribution.</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth all expenses payable by us in
connection with the sale of the securities being registered.&nbsp;
All the amounts shown are estimates except for the SEC registration
fee.</p>

<div align="center">
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td valign="top">
<p>SEC registration
fee.......................................................................</p>
</td>
<td valign="top" align="right">
<p>$117,700</p>
</td>
</tr>

<tr>
<td valign="top">
<p>NYSE listing
fees...........................................................................</p>
</td>
<td valign="top" align="right">
<p>2,500</p>
</td>
</tr>

<tr>
<td valign="top">
<p>Accounting fees and expenses
........................................................</p>
</td>
<td valign="top" align="right">
<p>18,000</p>
</td>
</tr>

<tr>
<td valign="top">
<p>Legal fees and expenses of our
counsel...........................................</p>
</td>
<td valign="top" align="right">
<p>50,000</p>
</td>
</tr>

<tr>
<td valign="top">
<p>Printing and
engraving.....................................................................</p>
</td>
<td valign="top" align="right">
<p>5,000</p>
</td>
</tr>

<tr>
<td valign="top">
<p>
Other.............................................................................................</p>
</td>
<td valign="top" align="right">
<div>
<p>6,800</p>
</div>
</td>
</tr>

<tr>
<td valign="top">
<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Total....................................................................................</p>
</td>
<td valign="top" align="right">
<div>
<p>$200,000</p>
</div>
</td>
</tr>
</table>
</div>

<p><b>Item 15.&nbsp; Indemnification of Directors and Officers.</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a California corporation.&nbsp; Section 317 of the
California Corporations Code provides for indemnification of a
corporation&rsquo;s directors and officers under certain
circumstances.&nbsp; Our articles of incorporation authorize us to
provide indemnification of any person who is or was our director,
officer, employee or other agent, or is or was serving at our
request as a director, officer, employee or agent of another
foreign or domestic corporation, partnership, joint venture, trust
or other enterprise, or was a director, officer, employee or agent
of a foreign or domestic corporation which was a predecessor
corporation of us or of another enterprise at the request of the
predecessor corporation through our bylaws, resolutions of our
board of directors, agreements with agents, vote of shareholders or
disinterested directors, or otherwise, in excess of the
indemnification otherwise permitted by Section 317 of the
California Corporations Code, subject only to the applicable limits
set forth in Section 204 of the California Corporations Code.&nbsp;
Our articles of incorporation also eliminate the liability of our
directors to the fullest extent permissible by California
law.&nbsp; Our board of directors has adopted a resolution
regarding our policy of indemnification and we maintain insurance
which insures our directors and officers against certain
liabilities.</p>

<p><b>Item 16.&nbsp; Exhibits.</b></p>

<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td valign="top">
<p><b>Exhibit <u>Number</u></b></p>
</td>
<td valign="bottom">
<p><b><u>Description</u></b></p>
</td>
</tr>

<tr>
<td valign="top">
<p>1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
</td>
<td valign="top">
<p>Form of Underwriting Agreement.*</p>
</td>
</tr>

<tr>
<td valign="top">
<p>1.2</p>
</td>
<td valign="top">
<p>Form of Distribution Agreement.*</p>
</td>
</tr>

<tr>
<td valign="top">
<p>4.1</p>
</td>
<td valign="top">
<p>Restated Articles of Incorporation of the Registrant
(incorporated by reference to Exhibit 3.1 of the Registrant&rsquo;s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2003,
File No. 1-12609).</p>
</td>
</tr>

<tr>
<td valign="top">
<p>4.2</p>
</td>
<td valign="top">
<p>By-Laws of the Registrant amended as of January 1, 2005&nbsp;
(incorporated by reference to Exhibit 3.3 of the Registrant&rsquo;s
Annual&nbsp; Report on Form 10-K for the year ended December&nbsp;
31, 2004, File No. 1-12609).</p>
</td>
</tr>

<tr>
<td valign="top">
<p>4.3</p>
</td>
<td valign="top">
<p>By-Laws of the Registrant amended as of April 20, 2005&nbsp;
(incorporated by reference to Exhibit 3.4 of the Registrant&rsquo;s
Annual Report on Form 10-K for the year ended December&nbsp; 31,
2004, File No. 1-12609).</p>
</td>
</tr>

<tr>
<td valign="top">
<p>5.1</p>
</td>
<td valign="top">
<p>Opinion of Gary P. Encinas.**</p>
</td>
</tr>

<tr>
<td valign="top">
<p>23.1</p>
</td>
<td valign="top">
<p>Consent of Deloitte &amp; Touche LLP.</p>
</td>
</tr>

<tr>
<td valign="top">
<p>23.2</p>
</td>
<td valign="top">
<p>Consent of Gary P. Encinas&nbsp; (included in Exhibit
5.1).**</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.1</p>
</td>
<td valign="top">
<p>Powers of Attorney**.</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.2</p>
</td>
<td valign="top">
<p>Resolution of the Board of Directors authorizing the execution
of the Registration Statement.**</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.3</p>
</td>
<td valign="top">
<p>Power of Attorney of Peter A. Darbee</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.4</p>
</td>
<td valign="top">
<p>Power of Attorney of Christopher P. Johns</p>
</td>
</tr>

<tr>
<td colspan="2" valign="top">
<p>__________________</p>

<p>*&nbsp; To be filed by amendment or as an exhibit to a report
filed under the Securities Exchange Act of 1934, as amended, and
incorporated herein by reference.</p>

<p>**&nbsp; Previously filed.</p>
</td>
</tr>
</table>

<p><b>Item 17.&nbsp; Undertakings.</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes:</p>

<blockquote>

<p>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
To file, during any period in which offers or sales are being made,
a post-effective amendment to this registration statement:</p>

<p>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to include any prospectus required by Section&nbsp;10(a)(3) of the
Securities Act of 1933;</p>

<p>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the registration statement; and</p>

<p>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to include any material information with respect to the plan of
distribution not previously disclosed in the registration statement
or any material change to such information in the registration
statement;</p>

</blockquote>

<p>provided, however, that paragraphs&nbsp;1(a) and 1(b) do not
apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in
periodic reports filed with or furnished to the SEC by the
registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the
Securities Exchange Act of 1934 that are incorporated by reference
in the registration statement.</p>

<blockquote>

<p>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering
thereof.</p>

<p>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.</p>

<p>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
That, for purposes of determining any liability under the
Securities Act of 1933, each filing of the registrant&rsquo;s
annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of&nbsp;
an employee benefit plan&rsquo;s annual report pursuant to
Section&nbsp;15(d) of the Securities Exchange Act of 1934) that is
incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering
thereof.</p>

<p>(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the registrant pursuant to the provisions
described under Item&nbsp;15 above, or otherwise, the registrant
has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore,
unenforceable.&nbsp; In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in
the Securities Act of 1933 and will be governed by the final
adjudication of such issue.</p>

<p>(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
For purposes of determining any liability under the Securities Act
of 1933, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A
and contained in a form of prospectus filed by a registrant
pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities
Act of 1933 shall be deemed to be part of this registration
statement as of the time it was declared effective.</p>

<p>(7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
For the purpose of determining any liability under the Securities
Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial bona
fide offering thereof.</p>

</blockquote>
<hr>

<b><br clear="all">
</b>

<p align="center"><b>SIGNATURES</b></p>

<p>Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-3 and has
duly caused this Amendment No. 1 to the Registration Statement to
be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of San Francisco, State of California, on
March 16, 2005.</p>

<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PG&amp;E CORPORATION</b><br>
<br>
<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By&nbsp;&nbsp; <u>PETER A.
DARBEE*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>
</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Peter A. Darbee<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and President</p>

<p>Pursuant to the requirements of the Securities Act of 1933, this
Amendment No. 1 to the Registration Statement has been signed by
the following persons in the capacities and on the dates
indicated.</p>

<table border="0" cellspacing="0" cellpadding="0" width="680">
<tr>
<td valign="top" width="157">
<p align="center"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Signature&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="377">
<p align="center"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
</td>
<td valign="top" width="16"></td>
<td valign="top" width="104">
<p align="center"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
</td>
</tr>

<tr>
<td valign="bottom" width="157">
<p><u>Robert D. Glynn, Jr.*</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Chairman of the Board of Directors</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>Robert D. Glynn, Jr.</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>Peter A. Darbee*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Chief Executive Officer, President and Director (Principal
Executive Officer)</p>
</td>
<td valign="top" width="16">&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td rowspan="2" valign="top" width="104">
<p>March&nbsp;16,&nbsp;&nbsp;2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>Peter A. Darbee</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>Christopher P. Johns*</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Senior Vice President, Chief Financial Officer and Controller
(Principal Financial and Accounting Officer)</p>
</td>
<td valign="top" width="16"></td>
<td valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>Christopher P. Johns</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
<td valign="top" width="104"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>David R. Andrews*</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>David R. Andrews</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104"></td>
</tr>

<tr>
<td valign="top" width="157">
<p>Leslie S. Biller</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>David A. Coulter*&nbsp;&nbsp;</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>David A. Coulter</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>C. Lee Cox*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>C. Lee Cox</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>David M. Lawrence*</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>David M. Lawrence M.D<br>
</p>
</td>
<td valign="top" width="16">&nbsp;&nbsp;&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>Mary S. Metz*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>Mary S. Metz</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104"></td>
</tr>

<tr>
<td valign="top" width="157">
<p>Barbara L. Rambo</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>Barry Lawson Williams*</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377">
<p>Director</p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">
<p>March 16, 2005</p>
</td>
</tr>

<tr>
<td valign="top" width="157">
<p>Barry Lawson Williams</p>
</td>
<td valign="top" width="16">&nbsp;
  <p>&nbsp;</td>
<td valign="top" width="16"></td>
</tr>

<tr>
<td valign="top" width="157">
<p><u>*By:&nbsp; /s/ G. P. Encinas</u></p>
</td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="377"></td>
<td valign="top" width="16"></td>
<td rowspan="2" valign="top" width="104">March 16, 2005</td>
</tr>

<tr>
<td valign="top" width="157">
<p>Gary P. Encinas<br>
 Attorney-in-fact</p>
</td>
<td valign="top" width="16"></td>
<td valign="top" width="16"></td>
</tr>
</table>
</div>

<hr>
&nbsp;

<div>
<p align="center"><b>INDEX TO EXHIBITS</b></p>

<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td valign="top">
<p><b>Exhibit <u>Number</u></b></p>
</td>
<td valign="bottom">
<p><b><u>Description</u></b></p>
</td>
</tr>

<tr>
<td valign="top">
<p>1.1</p>
</td>
<td valign="top">
<p>Form of Underwriting Agreement.*</p>
</td>
</tr>

<tr>
<td valign="top">
<p>1.2</p>
</td>
<td valign="top">
<p>Form of Distribution Agreement.*</p>
</td>
</tr>

<tr>
<td valign="top">
<p>4.1</p>
</td>
<td valign="top">
<p>Restated Articles of Incorporation of the Registrant
(incorporated by reference to Exhibit 3.1 of the Registrant&rsquo;s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2003,
File No. 1-12609).</p>
</td>
</tr>

<tr>
<td valign="top">
<p>4.2</p>
</td>
<td valign="top">
<p>By-Laws of the Registrant amended as of January 1, 2005
(incorporated by reference to Exhibit 3.2 of the Registrant&rsquo;s
Annual&nbsp; Report on Form 10-K for the year&nbsp; ended December
31, 2004, File No. 1-12609).</p>
</td>
</tr>

<tr>
<td valign="top">
<p>4.3</p>
</td>
<td valign="top">
<p>By-Laws of the Registrant amended as of April 20, 2005&nbsp;
(incorporated by reference to Exhibit 3.4 of the Registrant&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2004,
File No. 1-12609).</p>
</td>
</tr>

<tr>
<td valign="top">
<p>5.1</p>
</td>
<td valign="top">
<p>Opinion of Gary P. Encinas.**</p>
</td>
</tr>

<tr>
<td valign="top">
<p>23.1</p>
</td>
<td valign="top">
<p>Consent of Deloitte &amp; Touche LLP.</p>
</td>
</tr>

<tr>
<td valign="top">
<p>23.2</p>
</td>
<td valign="top">
<p>Consent of Gary P. Encinas (included in Exhibit 5.1).**</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.1</p>
</td>
<td valign="top">
<p>Powers of Attorney**.</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.2</p>
</td>
<td valign="top">
<p>Resolution of the Board of Directors authorizing the execution
of the Registration Statement.**</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.3</p>
</td>
<td valign="top">
<p>Power of Attorney of Peter A. Darbee</p>
</td>
</tr>

<tr>
<td valign="top">
<p>24.4</p>
</td>
<td valign="top">
<p>Power of Attorney of Christopher P. Johns</p>
</td>
</tr>

<tr>
<td colspan="2" valign="top">
<p>__________________</p>

<p>*&nbsp; To be filed by amendment or as an exhibit to a report
filed under the Securities Exchange Act of 1934, as amended, and
incorporated herein by reference.</p>

<p>**&nbsp; Previously filed.</p>
</td>
</tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit23-1.htm
<DESCRIPTION>CONSENT OF D&T
<TEXT>
<html>
<head>
<title>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</title>
</head>
<body>
<div>
<p align="right"><b>Exhibit 23.1<br />
</b></p>

<p align="center"><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM<br />
</b></p>

<p>We consent to the incorporation by reference in this Amendment
No. 1 to Registration Statement No. 333-121518 on Form S-3 of our
reports dated February 16, 2005, (which report on the financial
statements expresses an unqualified opinion and includes an
explanatory paragraph relating to accounting changes) relating to
the financial statements and financial statement schedules of
PG&amp;E Corporation and subsidiaries and to management&rsquo;s
report on the effectiveness of internal control over financial
reporting, appearing in the Annual Report on Form 10-K of PG&amp;E
Corporation and subsidiaries for the year ended December 31, 2004,
and to the reference to us under the heading &ldquo;Experts&rdquo;
in the Prospectus, which is part of this Registration
Statement.</p>

<p><u>DELOITTE &amp; TOUCHE LLP</u></p>

<p><i>DELOITTE &amp; TOUCHE LLP</i></p>

<p>San Francisco, California<br />
March 15, 2005</p>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3
<SEQUENCE>3
<FILENAME>exhibit24-3.htm
<DESCRIPTION>POWERS FOR PETER DARBEE
<TEXT>
<html>
<head>
<title>DARBEE AND JOHNS POWERS</title>
</head>
<body>
<div>
<p align="right"><b><font size="3" face="Times New Roman">Exhibit 24.3</font></b></p>

<p align="center"><b><font size="3" face="Times New Roman">POWER OF
ATTORNEY</font></b></p>

<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PETER
A. DARBEE, the undersigned, Chief Executive Officer, President and
a Director of PG&amp;E Corporation (the &ldquo;Corporation&rdquo;),
hereby constitutes and appoints LINDA Y.H. CHENG, WONDY S. LEE,
ERIC MONTIZAMBERT, GARY P. ENCINAS, JOHN E. FORD, KATHLEEN M. HAYES
and DOREEN A. LUDEMANN, and each of them, as his attorneys in fact
with full power of substitution and resubstitution to sign and file
with the Securities and Exchange Commission in his capacity as
Chief Executive Officer, President (principal executive officer)
and a Director of the Corporation:<br>
<br>
</font></p>

<div align="center">
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top">
<p><font size="3" face="Times New Roman">a Registration Statement
filed or to be filed with the Securities and Exchange
Commission</font></p>
</td>
</tr>

<tr>
<td valign="top"></td>
<td valign="top">
<p><font size="3" face="Times New Roman">relating to the issuance
and sale, from time to time, of securities with an aggregate
offering price</font></p>
</td>
</tr>

<tr>
<td valign="top"></td>
<td valign="top">
<p><font size="3" face="Times New Roman">of up to $2.0 billion or
the equivalent thereof in one or more foreign currencies;
and</font></p>
</td>
</tr>

<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top"></td>
</tr>

<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)</font></p>
</td>
<td valign="top">
<p><font size="3" face="Times New Roman">any and all amendments and
other filings or documents related to such Registration
Statement.</font></p>
</td>
</tr>
</table>
</div>

<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned hereby ratifies all that said attorneys in fact or any
of them may do or cause to be done by virtue hereof.</font></p>

<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN
WITNESS WHEREOF, I have signed these presents as of this 15th day
of March, 2005.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="640">
<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top">
<p><font size="3" face="Times New Roman"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Peter
A.
Darbee&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font></p>
</td>
</tr>

<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Peter A.
Darbee</font></p>
</td>
</tr>
</table>

<p><b><font size="3" face="Times New Roman"><br clear="all" />
</font></b></p>

</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.4
<SEQUENCE>4
<FILENAME>exhibit24-4.htm
<DESCRIPTION>POWERS FOR CHRISTOPHER JOHNS
<TEXT>
<html>

<head>
     <title>Exhibit 24</title>
</head>

<body>

<div>

<p align="right"><b>Exhibit 24.4</b></p>

<p align="center"><b><font size="3" face="Times New Roman">POWER OF
ATTORNEY</font></b></p>

<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CHRISTOPHER
P. JOHNS, the undersigned, Senior Vice President, Chief Financial
Officer and Controller of PG&amp;E Corporation (the
&ldquo;Corporation&rdquo;), hereby constitutes and appoints LINDA Y.H. CHENG, WONDY S. LEE, ERIC
MONTIZAMBERT, GARY P. ENCINAS, JOHN
E. FORD, KATHLEEN M. HAYES and DOREEN A. LUDEMANN, and each of
them, as his attorneys in fact with full power of substitution and
resubstitution to sign and file with the Securities and Exchange
Commission in his capacity as Senior Vice President, Chief
Financial Officer and Controller (principal financial and
accounting officer) of the Corporation:</font></p>

<div align="center">
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top">
<p><font size="3" face="Times New Roman">a Registration Statement
filed or to be filed with the Securities and Exchange
Commission</font></p>
</td>
</tr>

<tr>
<td valign="top"></td>
<td valign="top">
<p><font size="3" face="Times New Roman">relating to the issuance
and sale, from time to time, of securities with an aggregate
offering price</font></p>
</td>
</tr>

<tr>
<td valign="top"></td>
<td valign="top">
<p><font size="3" face="Times New Roman">of up to $2.0 billion or
the equivalent thereof in one or more foreign currencies;
and</font></p>
</td>
</tr>

<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top"></td>
</tr>

<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)</font></p>
</td>
<td valign="top">
<p><font size="3" face="Times New Roman">any and all amendments and
other filings or documents related to such Registration
Statement.</font></p>
</td>
</tr>
</table>
</div>

<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned hereby ratifies all that said attorneys in fact or any
of them may do or cause to be done by virtue hereof.</font></p>

<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN
WITNESS WHEREOF, I have signed these presents as of this 15th day
of March, 2005.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="640">
<tr>
<td valign="top"></td>
<td valign="top">
<p><font size="3" face="Times New Roman"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christopher
P.
Johns&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font></p>
</td>
</tr>

<tr>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td valign="top">
<p><font size="3" face=
"Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christopher P.
Johns</font></p>
</td>
</tr>
</table>

<p>&nbsp;</p>
</div>

</body>

</html>
</TEXT>
</DOCUMENT>
</SUBMISSION>
